Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 4,126–4,150 of 27,380 studies, newest first · page 166 of 1096.

June 2025 25

  1. 2025-06-01

    Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers

    ✓ Peer-reviewed Disease mechanisms Alzheimer s & Dementia

    Key finding: HIGHLIGHTS: Despite recent progress in Alzheimer's disease (AD) treatments for the general population-particularly monoclonal anti-amyloid therapies such as lecanemab and donanemab-individuals with Down syndrome (DS) were excluded from pivotal trials, leaving significant gaps in knowledge regarding safety and efficacy.

  2. 2025-06-01

    Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases

    ✓ Peer-reviewed Inflammation and the immune system Pharmaceuticals

    Key finding: The complexity of the above pathologies has clearly demonstrated that such single-target drugs are inadequate to achieve a successful therapeutic result.

  3. 2025-06-01
  4. 2025-06-01
  5. 2025-06-01

    Blood Uric Acid in Mild Cognitive Impairment: A Cross-Sectional Study of Older Chinese Adults

    ✓ Peer-reviewed Mild cognitive impairment Neuropsychiatric Disease and Treatment

    Key finding: A total of 90 (38.96%) participants were healthy and 141 (61.04%) had MCI. +4 more findings

  6. 2025-06-01

    Inequalities in Mild Cognitive Impairment Risk Among Chinese Middle-Aged and Older Adults: Insights from an Integrated Learning Model

    ✓ Peer-reviewed Mild cognitive impairment Risk Management and Healthcare Policy

    Key finding: The CNN-BiLSTM-Attention model demonstrated relatively promising predictive performance (AUC: 0.7317), with moderately high sensitivity (0.6902) and a high negative predictive value (NPV) of 0.9414. +4 more findings

  7. 2025-06-01

    Comparing clinical features of behavioral variant frontotemporal dementia and Alzheimer's disease using network analysis

    ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia

    Key finding: Both networks were densely connected, reflecting comorbidity between neuropsychiatric symptoms and cognitive scores. +4 more findings

  8. 2025-06-01

    A hypothesis explaining Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies overlap

    ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia

    Key finding: Lewy body-involving diseases (LBD) are commonly associated with Parkinson's disease (PD) featuring voluntary movement inhibition, due to dopaminergic neuron dysfunction in the substantia nigra.

  9. 2025-06-01

    TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementia

    ✓ Peer-reviewed Lewy body dementia Journal of Clinical Investigation

    Key finding: Our findings define changes in polyadenylation site selection as a previously understudied feature of TDP-43-driven disease pathology in ALS/FTD and highlight a potentially important mechanistic link between TDP-43 dysfunction and tau regulation.

  10. 2025-06-01

    A lifespan perspective on cognitive reserve and risk for dementia

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: Higher GCA was associated with lower dementia risk (hazard ratio = 0.865, 95% confidence interval = 0.756 to 0.990). +4 more findings

  11. 2025-06-01

    Leveraging Artificial Intelligence in the Diagnosis of Neurodegenerative Disorders (Alzheimer's and Dementia) and in Managing Medication Schedules"

    ✓ Peer-reviewed Digital health tools Damanhour Journal of Intelligent Systems and Informatics

    Key finding: The experimental results underscore that the proposed ordinal EfficientNetB0 architecture outperforms other models in fundamental structural tasks, characterized by minimal computational overhead, reduced susceptibility to overfitting, efficient memory utilization, and effective temporal regulation. +1 more finding

  12. 2025-06-01

    Detection of emergency department patients at risk of dementia through artificial intelligence

    ✓ Peer-reviewed Digital health tools Alzheimer s & Dementia

    Key finding: EDDA achieved an area under the receiver-operating characteristic curve (AUROC) of 0.85 in the test set and 0.93 in the validation set. +4 more findings

  13. 2025-06-01

    Impact of APOE4‐related dementia risk in underrepresented groups from the All of Us research program

    ✓ Peer-reviewed Disparities Alzheimer s & Dementia

    Key finding: There was a significantly higher risk of developing a dementia diagnosis in Hispanic/Latino and NHB participants than NHW participants and comparably increased dementia hazard ratios in the Hispanic/Latino, NHB, and NHW APOE4 carriers than non-carriers (hazard ratio [HR] [95% confidence interval {CI}] 1.54 [1.25-1.91], 1.25 [1.00-1.57], and 1.55 [1.40-1.72]). +4 more findings

  14. 2025-06-01

    Lifespan exposures to rural–urban conditions and later‐life cognitive function

    ✓ Peer-reviewed Disparities Alzheimer s & Dementia

    Key finding: Linear and logistic regression showed that childhood rural residence was associated with lower memory (standardized beta (β) = -1.68, 95% Confidence Interval (CI) [-2.39, -0.97]), executive function (β = -1.20, 95% CI [-1.84, -0.55]), and language fluency (β = -0.86, 95% CI [-1.64, -0.08]). +4 more findings

  15. 2025-06-01

    Ethnic Disparities and Inequalities in Dementia Care: An Extended Literature Review

    ✓ Peer-reviewed Disparities BJPsych Open

    Key finding: Across the literature, it is evident that health inequalities currently exist and exacerbate the disparities in the care of BAME dementia patients. +4 more findings

  16. 2025-06-01

    The Post-Traumatic Growth Experience in Family Caregivers of People with Dementia: A Descriptive Qualitative Study

    ✓ Peer-reviewed Caregiving Psychology Research and Behavior Management

    Key finding: Four themes were identified, along with eleven sub-themes associated with them: cognitive-behavioral shift (transitioning family roles, recognizing disease characteristics, focusing on health management, and responding positively and effectively); personal strength enhancement (enhancing coping capacity, increased psychological resilience and increased responsibility); improved relationships with others (harmonizing in family relations and benefiting from social interactions); and changes in life perceptions (reshaping of values, and reconstructing the meaning of life). +3 more findings

  17. 2025-06-01

    Competency‐based training boosts dementia knowledge and skills in home care workers

    ✓ Peer-reviewed Caregiving Alzheimer s & Dementia

    Key finding: The training significantly improved caregivers' dementia knowledge and self-efficacy but did not reduce caregivers' distress and depression, nor decrease care recipients' emergency room visits and hospitalizations. +4 more findings

  18. 2025-06-01

    Social support interventions for caregivers of older adults with dementia: a scoping review

    ✓ Peer-reviewed Caregiving BMJ Open

    Key finding: A total of 31 studies were selected for this review, revealing six distinct categories of social support interventions for caregivers of older adults with dementia. +4 more findings

  19. 2025-06-01

    Sense of Coherence and Caregiver Burden Among Informal Caregivers of People with Dementia in China: The Mediating Role of Coping Strategies

    ✓ Peer-reviewed Caregiving Psychology Research and Behavior Management

    Key finding: The caregiver burden was found at a moderate to severe level with the average score of 58.14(12.84). +4 more findings

  20. 2025-06-01

    Blood-brain barrier permeability changes and neuroinflammation in Alzheimer disease progression

    ✓ Peer-reviewed Brain scans and imaging International Journal of Biology Sciences

    Key finding: This research investigated how Blood-Brain Barrier (BBB) permeability shifts relate to neuroinflammatory marker profiles across early, moderate, and advanced stages of Alzheimer disease. +4 more findings

  21. 2025-06-01

    LUMEN: Prototype Conversational AI to Streamline Dementia Assessments

    ✓ Peer-reviewed Getting a diagnosis BJPsych Open

    Key finding: LUMEN demonstrated strong performance in distinguishing dementia from normal cognition (AUROC=0.89) but moderate subtype differentiation (AUROC=0.66). +4 more findings

  22. 2025-06-01
  23. 2025-06-01

    Autism, Diagnostics, and Dementia: A Consensus Report From the 2nd International Summit on Intellectual Disabilities and Dementia

    ✓ Peer-reviewed Getting a diagnosis International Journal of Geriatric Psychiatry

    Key finding: Diagnostic challenges stem from overlapping symptoms of co-occurring neurodevelopmental and psychiatric conditions, rendering standard dementia tools insufficient. +4 more findings

  24. 2025-06-01

    Lecanemab Binds to Transgenic Mouse Model‐Derived Amyloid‐β Fibril Structures Resembling Alzheimer's Disease Type I, Type II and Arctic Folds

    ✓ Peer-reviewed Treatments Neuropathology and Applied Neurobiology

    Key finding: Our results show that lecanemab exhibits high binding affinity to amyloid-β fibril structures that have a flexible N-terminus in common, as is the case for type I, type II and murine type III amyloid-β fibril polymorphs, which resemble or are identical to human structures observed in sporadic and familial cases of Alzheimer's disease, including a case with the Arctic (E22G) mutation. +4 more findings

  25. 2025-06-01

    “Real‐world” eligibility for anti‐amyloid treatment in a tertiary memory clinic setting

    ✓ Peer-reviewed Treatments Alzheimer s & Dementia

    Key finding: Of 1309 new patients, 514 (39% of new patients) had clinical mild cognitive impairment (MCI) or AD. +4 more findings

Browse the library by subject, with the full score breakdown →